Log In
Print
BCIQ
Print
Print this Print this
 

delayed-release posaconazole (Noxafil)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionDelayed-release tablet formulation of posaconazole, a P450 sterol C-14 alpha demethylase
Molecular Target
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today